Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Not yet recruiting 1Completed 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Observational 2Interventional 2

Sponsor

Cancer Type

Gastrointestinal 9Thoracic 5CNS 5Genitourinary 4Head & Neck 3Breast 2Tumor-Agnostic 1Other solid neoplasm 1Gynecologic 1

Conditions

Breast Neoplasms 2Disease 1

Interventions

Trastuzumab 696Paclitaxel 679Cyclophosphamide 634Docetaxel 554Capecitabine 468Letrozole 407Carboplatin 393Fulvestrant 379Doxorubicin 330Tamoxifen 288pembrolizumab 272Anastrozole 252Epirubicin 249exemestane 238pertuzumab 229Bevacizumab 214Radiotherapy 213Gemcitabine 211Vinorelbine 188palbociclib 183Lapatinib 175130-nm albumin-bound paclitaxel 168Albumin-Bound Paclitaxel 156Exercise 147Magnetic Resonance Spectroscopy 145eribulin 144Taxes 134Fluorouracil 131Everolimus 118Cisplatin 118

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Drug Delivery Systems × Breast × Clear all
NCT07487844 2026-03-23

Pulsed Electric Field Ablation for Metastatic Breast Cancer

University of California, San Francisco

Phase NA Not yet recruiting
20 enrolled
Breast

Breast Neoplasms

NCT01373671 2020-08-07

DBT

Siemens Medical Solutions USA - CSG

Phase NA Completed
764 enrolled 5 charts
Breast

Breast Neoplasms, Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡